Physician profile
Bryce Lunt
NPI 1396127635
$4,000.84
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $377 · 2021: $1,606 · 2022: $651 · 2023: $473 · 2024: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,248.75 | 2021 | |
| Abbvie INC. | $479.62 | 2021-2024 | |
| Amgen INC. | $475.60 | 2019-2024 | Krystexxa |
| Lilly USA, LLC | $189.14 | 2020-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $151.66 | 2019-2023 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.08 | 2020-2024 | Jardiance, Tradjenta, Synjardy |
| Pfizer INC. | $133.27 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $109.94 | 2020-2024 | Airsupra, Flumist Quadrivalent, Evusheld |
| Novo Nordisk INC | $108.61 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $108.36 | 2022 | |
| Merck Sharp & Dohme LLC | $90.64 | 2019-2022 | |
| Boston Scientific Corporation | $85.36 | 2022-2024 | Watchman Access System |
| Dynavax Technologies Corporation | $64.00 | 2019 | |
| Amarin Pharma, INC. | $47.42 | 2019-2020 | |
| Lucid Diagnostics INC. | $44.73 | 2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Lunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.